GE HEALTHCARE TECHNOLOGY (GEHC) Fundamental Analysis & Valuation
NASDAQ:GEHC • US36266G1076
Current stock price
74.79 USD
+0.96 (+1.3%)
Last:
This GEHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. GEHC Profitability Analysis
1.1 Basic Checks
- In the past year GEHC was profitable.
- GEHC had a positive operating cash flow in the past year.
- GEHC had positive earnings in each of the past 5 years.
- In the past 5 years GEHC always reported a positive cash flow from operatings.
1.2 Ratios
- GEHC has a Return On Assets of 5.65%. This is amongst the best in the industry. GEHC outperforms 81.38% of its industry peers.
- GEHC has a Return On Equity of 20.09%. This is amongst the best in the industry. GEHC outperforms 94.15% of its industry peers.
- GEHC's Return On Invested Capital of 7.81% is amongst the best of the industry. GEHC outperforms 81.91% of its industry peers.
- GEHC had an Average Return On Invested Capital over the past 3 years of 8.25%. This is in line with the industry average of 9.15%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.65% | ||
| ROE | 20.09% | ||
| ROIC | 7.81% |
ROA(3y)5.31%
ROA(5y)6.29%
ROE(3y)21.03%
ROE(5y)19.41%
ROIC(3y)8.25%
ROIC(5y)9.14%
1.3 Margins
- GEHC's Profit Margin of 10.11% is amongst the best of the industry. GEHC outperforms 82.98% of its industry peers.
- In the last couple of years the Profit Margin of GEHC has declined.
- Looking at the Operating Margin, with a value of 13.40%, GEHC belongs to the top of the industry, outperforming 81.38% of the companies in the same industry.
- In the last couple of years the Operating Margin of GEHC has declined.
- GEHC has a worse Gross Margin (39.98%) than 67.02% of its industry peers.
- GEHC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.4% | ||
| PM (TTM) | 10.11% | ||
| GM | 39.98% |
OM growth 3Y-0.87%
OM growth 5Y-3.3%
PM growth 3Y-1.1%
PM growth 5Y-34%
GM growth 3Y0.71%
GM growth 5Y0.28%
2. GEHC Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), GEHC is creating some value.
- Compared to 1 year ago, GEHC has less shares outstanding
- The number of shares outstanding for GEHC has been increased compared to 5 years ago.
- Compared to 1 year ago, GEHC has about the same debt to assets ratio.
2.2 Solvency
- GEHC has an Altman-Z score of 1.88. This is not the best score and indicates that GEHC is in the grey zone with still only limited risk for bankruptcy at the moment.
- GEHC's Altman-Z score of 1.88 is in line compared to the rest of the industry. GEHC outperforms 57.98% of its industry peers.
- The Debt to FCF ratio of GEHC is 6.67, which is on the high side as it means it would take GEHC, 6.67 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of GEHC (6.67) is better than 73.40% of its industry peers.
- A Debt/Equity ratio of 0.92 indicates that GEHC is somewhat dependend on debt financing.
- GEHC has a Debt to Equity ratio of 0.92. This is in the lower half of the industry: GEHC underperforms 76.06% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | 6.67 | ||
| Altman-Z | 1.88 |
ROIC/WACC0.99
WACC7.93%
2.3 Liquidity
- GEHC has a Current Ratio of 1.37. This is a normal value and indicates that GEHC is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of GEHC (1.37) is worse than 81.91% of its industry peers.
- GEHC has a Quick Ratio of 1.13. This is a normal value and indicates that GEHC is financially healthy and should not expect problems in meeting its short term obligations.
- With a Quick ratio value of 1.13, GEHC is not doing good in the industry: 77.13% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.13 |
3. GEHC Growth Analysis
3.1 Past
- GEHC shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.00%.
- GEHC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -31.63% yearly.
- The Revenue has been growing slightly by 4.85% in the past year.
- GEHC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.74% yearly.
EPS 1Y (TTM)2%
EPS 3Y2.54%
EPS 5Y-31.63%
EPS Q2Q%-0.69%
Revenue 1Y (TTM)4.85%
Revenue growth 3Y3.99%
Revenue growth 5Y3.74%
Sales Q2Q%7.13%
3.2 Future
- The Earnings Per Share is expected to grow by 8.20% on average over the next years. This is quite good.
- GEHC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.05% yearly.
EPS Next Y12.83%
EPS Next 2Y11.38%
EPS Next 3Y11.08%
EPS Next 5Y8.2%
Revenue Next Year5.48%
Revenue Next 2Y4.99%
Revenue Next 3Y4.9%
Revenue Next 5Y4.05%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. GEHC Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 16.33, which indicates a correct valuation of GEHC.
- GEHC's Price/Earnings ratio is rather cheap when compared to the industry. GEHC is cheaper than 86.17% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 27.18. GEHC is valued slightly cheaper when compared to this.
- With a Price/Forward Earnings ratio of 14.47, GEHC is valued correctly.
- Based on the Price/Forward Earnings ratio, GEHC is valued cheaper than 89.36% of the companies in the same industry.
- GEHC is valuated cheaply when we compare the Price/Forward Earnings ratio to 37.96, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.33 | ||
| Fwd PE | 14.47 |
4.2 Price Multiples
- 88.30% of the companies in the same industry are more expensive than GEHC, based on the Enterprise Value to EBITDA ratio.
- GEHC's Price/Free Cash Flow ratio is rather cheap when compared to the industry. GEHC is cheaper than 86.17% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 22.68 | ||
| EV/EBITDA | 11.75 |
4.3 Compensation for Growth
- GEHC's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- GEHC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.27
PEG (5Y)N/A
EPS Next 2Y11.38%
EPS Next 3Y11.08%
5. GEHC Dividend Analysis
5.1 Amount
- With a yearly dividend of 0.19%, GEHC is not a good candidate for dividend investing.
- GEHC's Dividend Yield is rather good when compared to the industry average which is at 0.24. GEHC pays more dividend than 89.36% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.82, GEHC's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.19% |
5.2 History
- GEHC has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
- 3.07% of the earnings are spent on dividend by GEHC. This is a low number and sustainable payout ratio.
DP3.07%
EPS Next 2Y11.38%
EPS Next 3Y11.08%
GEHC Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:GEHC (4/14/2026, 1:17:41 PM)
74.79
+0.96 (+1.3%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-04 2026-02-04/bmo
Earnings (Next)04-29 2026-04-29
Inst Owners93.2%
Inst Owner Change-7.81%
Ins Owners0.35%
Ins Owner Change0.63%
Market Cap34.13B
Revenue(TTM)20.63B
Net Income(TTM)2.08B
Analysts78.57
Price Target94.99 (27.01%)
Short Float %2.72%
Short Ratio3.4
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.19% |
Yearly Dividend0.14
Dividend Growth(5Y)N/A
DP3.07%
Div Incr Years2
Div Non Decr Years2
Ex-Date04-02 2026-04-02 (0.035)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.4%
Min EPS beat(2)-0.16%
Max EPS beat(2)0.96%
EPS beat(4)3
Avg EPS beat(4)5.61%
Min EPS beat(4)-0.16%
Max EPS beat(4)13.24%
EPS beat(8)6
Avg EPS beat(8)4.83%
EPS beat(12)10
Avg EPS beat(12)5.31%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.59%
Min Revenue beat(2)-0.75%
Max Revenue beat(2)-0.44%
Revenue beat(4)1
Avg Revenue beat(4)-0.46%
Min Revenue beat(4)-1.09%
Max Revenue beat(4)0.42%
Revenue beat(8)1
Avg Revenue beat(8)-1.72%
Revenue beat(12)2
Avg Revenue beat(12)-1.42%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.31%
PT rev (3m)3.8%
EPS NQ rev (1m)-1.21%
EPS NQ rev (3m)4.38%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)3.14%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.61%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.18%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.33 | ||
| Fwd PE | 14.47 | ||
| P/S | 1.65 | ||
| P/FCF | 22.68 | ||
| P/OCF | 17.17 | ||
| P/B | 3.29 | ||
| P/tB | N/A | ||
| EV/EBITDA | 11.75 |
EPS(TTM)4.58
EY6.12%
EPS(NY)5.17
Fwd EY6.91%
FCF(TTM)3.3
FCFY4.41%
OCF(TTM)4.35
OCFY5.82%
SpS45.2
BVpS22.75
TBVpS-9.29
PEG (NY)1.27
PEG (5Y)N/A
Graham Number48.42
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.65% | ||
| ROE | 20.09% | ||
| ROCE | 9.94% | ||
| ROIC | 7.81% | ||
| ROICexc | 9.32% | ||
| ROICexgc | 25% | ||
| OM | 13.4% | ||
| PM (TTM) | 10.11% | ||
| GM | 39.98% | ||
| FCFM | 7.3% |
ROA(3y)5.31%
ROA(5y)6.29%
ROE(3y)21.03%
ROE(5y)19.41%
ROIC(3y)8.25%
ROIC(5y)9.14%
ROICexc(3y)9.48%
ROICexc(5y)10.1%
ROICexgc(3y)28.41%
ROICexgc(5y)36.05%
ROCE(3y)10.49%
ROCE(5y)11.63%
ROICexgc growth 3Y-16.74%
ROICexgc growth 5Y-17.72%
ROICexc growth 3Y-3.85%
ROICexc growth 5Y-6.16%
OM growth 3Y-0.87%
OM growth 5Y-3.3%
PM growth 3Y-1.1%
PM growth 5Y-34%
GM growth 3Y0.71%
GM growth 5Y0.28%
F-Score4
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.92 | ||
| Debt/FCF | 6.67 | ||
| Debt/EBITDA | 2.85 | ||
| Cap/Depr | 83.39% | ||
| Cap/Sales | 2.34% | ||
| Interest Coverage | 5.29 | ||
| Cash Conversion | 59.47% | ||
| Profit Quality | 72.18% | ||
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.13 | ||
| Altman-Z | 1.88 |
F-Score4
WACC7.93%
ROIC/WACC0.99
Cap/Depr(3y)71.99%
Cap/Depr(5y)60.92%
Cap/Sales(3y)2.12%
Cap/Sales(5y)1.89%
Profit Quality(3y)91.25%
Profit Quality(5y)85.67%
High Growth Momentum
Growth
EPS 1Y (TTM)2%
EPS 3Y2.54%
EPS 5Y-31.63%
EPS Q2Q%-0.69%
EPS Next Y12.83%
EPS Next 2Y11.38%
EPS Next 3Y11.08%
EPS Next 5Y8.2%
Revenue 1Y (TTM)4.85%
Revenue growth 3Y3.99%
Revenue growth 5Y3.74%
Sales Q2Q%7.13%
Revenue Next Year5.48%
Revenue Next 2Y4.99%
Revenue Next 3Y4.9%
Revenue Next 5Y4.05%
EBIT growth 1Y5.26%
EBIT growth 3Y3.09%
EBIT growth 5Y0.31%
EBIT Next Year31.17%
EBIT Next 3Y14.85%
EBIT Next 5Y12.12%
FCF growth 1Y-2.9%
FCF growth 3Y-5.84%
FCF growth 5Y-8.6%
OCF growth 1Y1.85%
OCF growth 3Y-2.03%
OCF growth 5Y-5.37%
GE HEALTHCARE TECHNOLOGY / GEHC Fundamental Analysis FAQ
What is the fundamental rating for GEHC stock?
ChartMill assigns a fundamental rating of 5 / 10 to GEHC.
What is the valuation status for GEHC stock?
ChartMill assigns a valuation rating of 7 / 10 to GE HEALTHCARE TECHNOLOGY (GEHC). This can be considered as Undervalued.
Can you provide the profitability details for GE HEALTHCARE TECHNOLOGY?
GE HEALTHCARE TECHNOLOGY (GEHC) has a profitability rating of 7 / 10.
What are the PE and PB ratios of GE HEALTHCARE TECHNOLOGY (GEHC) stock?
The Price/Earnings (PE) ratio for GE HEALTHCARE TECHNOLOGY (GEHC) is 16.33 and the Price/Book (PB) ratio is 3.29.
What is the earnings growth outlook for GE HEALTHCARE TECHNOLOGY?
The Earnings per Share (EPS) of GE HEALTHCARE TECHNOLOGY (GEHC) is expected to grow by 12.83% in the next year.